HomeZEAL • CPH
add
Zealand Pharma A/S
Previous close
kr 343.70
Day range
kr 314.00 - kr 335.10
Year range
kr 314.00 - kr 967.50
Market cap
24.52B DKK
Avg Volume
419.23K
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Market news
AInvest
57 minutes ago
Tech Giants Drive DJIA Futures Surge Amid Inflation Concerns and Earnings Boost
3.03%
1.76%
1.23%
Financials
Income Statement
Revenue
Net income
| (DKK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 8.09M | -46.37% |
Operating expense | 414.72M | 55.72% |
Net income | -335.34M | -46.66% |
Net profit margin | -4.14K | -173.48% |
Earnings per share | -4.75 | -28.03% |
EBITDA | -401.08M | -60.93% |
Effective tax rate | 0.41% | — |
Balance Sheet
Total assets
Total liabilities
| (DKK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.54B | 163.42% |
Total assets | 9.12B | 154.33% |
Total liabilities | 813.74M | 8.67% |
Total equity | 8.31B | — |
Shares outstanding | 70.69M | — |
Price to book | 2.92 | — |
Return on assets | -10.93% | — |
Return on capital | -11.49% | — |
Cash Flow
Net change in cash
| (DKK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -335.34M | -46.66% |
Cash from operations | -500.79M | -123.89% |
Cash from investing | 554.62M | 140.23% |
Cash from financing | -791.00K | -100.04% |
Net change in cash | 50.12M | -77.53% |
Free cash flow | -398.07M | -169.78% |
About
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Founded
Apr 1, 1997
Website
Employees
385
